Vnitr Lek 2011, 57(11):919-922

Modern technologies in diabetology. CSII (Continuous Subcutaneous Insulin Infusion) and CGM (Continuous Glucose Monitoring) in clinical practice

J. Olšovský
Diabetologické centrum II. interní kliniky Lékařské fakulty MU a FN u sv. Anny Brno, přednosta prof. MUDr. Miroslav Souček, CSc.

Modern diabetology is closely associated with the use of modern technologies; glucometres are now widely clinically used and it is difficult to envisage diabetology without these devices. At present, CSII and CGM are less frequently used but they certainly are equally exciting. The author discusses both methods individually as well their interrelationship, mainly from the perspective of their optimal use.

Keywords: diabetes mellitus; continuous subcutaneous insulin infusion; continuous glucose monitoring

Received: September 28, 2011; Published: November 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Olšovský J. Modern technologies in diabetology. CSII (Continuous Subcutaneous Insulin Infusion) and CGM (Continuous Glucose Monitoring) in clinical practice. Vnitr Lek. 2011;57(11):919-922.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Pickup JC, Keen H, Parsons JA et al. Continuous subcutaneous insulin infusion: an aproach to achieving normoglycemia. Br Med J 1978; 1: 204-207. Go to original source... Go to PubMed...
    2. Pickup J, Keen H. Continuous subcutaneous insulin infusion et 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes. Diabetes Care 2002; 25: 593-598. Go to original source... Go to PubMed...
    3. Olšovský J. Inzulínová pumpa. In: Perušičová J et al (eds). Trendy soudobé diabetologie. sv. 9. Praha: Galén 2004: 49-71.
    4. Brož J, Kožnarová R, Bartášková D et al. Současné možnosti léčby diabetes mellitus pomocí inzulínových pump. XLII. Diabetologické dny, Luhačovice, 20.-22. 4. 2006. Diabetologie, Metabolismus, Endokrynologie, Výživa 2006; 4: 179-186.
    5. Jankovec Z, Krčma M, Lacigová S et al. Registr pacientů léčených inzulínovou pumpou v České republice. XLII. Diabetologické dny, Luhačovice, 20.-22. 4. 2006. Diabetologie, Metabolismus, Endokrynologie, Výživa 2004; Suppl 1: 22.
    6. Jankovec Z, Čechurová D, Krčma M et al. Dlouhodobý efekt léčby inzulínovou pumpou (CSII) - výsledky registru pacientů léčených CSII v České republice. XLII. Diabetologické dny, Luhačovice, 20.-22. 4. 2006. Diabetologie, Metabolismus, Endokrynologie, Výživa 2006; Suppl 2: 26.
    7. Markus AO. Patient selection for insulin pump therapy. Practical Diabetology Nov 1992; 14: 12-18.
    8. Jornsay DL, Duckles AE, Hankinson JP. Psychological considerations for patient selection and adjustment to insulin pump therapy. Diabetes Educ 1988; 14: 291-296. Go to original source... Go to PubMed...
    9. Olšovský J, Beránek M. Vliv dlouhodobé terapie inzulínovou pumpou (CSII) u pacientů s diabetes mellitus 1. typu na metabolickou kompenzaci a výskyt hypoglykemií. Porovnání s intenzifikovanou konvenční inzulinovou terapií. Vnitř Lék 2007; 6: 637-645.
    10. Mecklenburg RS, Benson EA, Benson JW Jr et al. Acute complications associated with insulin infusion pump therapy. Report of experience with 161 patients. JAMA 1984: 252: 3265-3269. Go to original source... Go to PubMed...
    11. Bending J, Pickup JC, Keen H. The frequency of diabetic ketoacidosis and hypoglycemic coma during treatment with continuous subcutaneous insulin infusion. Audit of medical care. Am J Med 1985; 79: 685-691. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.